HomeNews │ version:繁體中文
 
首頁 產品資訊 Gastro-intestinal > [cBc] Fulisay Oral Solution
 
[cBc] Fulisay Oral Solution
[cBc] Fulisay Oral Solution
Manufactory: CBC Biotechnological & Pharmaceutical Co., Ltd.
NHI Code:  
License Number:
DOH-PM-055294
Contents:
Monobasic sodium phosphate, monohydrate 480 mg/ml
Dibasic sodium phosphate, heptahydrate 180 mg/ml
Indications: Relief of occasional constipation & bowel cleansing regimen in preparing the patient for surgery, x-ray or endoscopic exam.
ATC Code:
A06AD17 Sodium phosphate 50 g O
AHFS Code:
56120000 Cathartics and laxatives
Pregnancy Category: Pregnancy Category C
Mechanism:  
Dosage:

1. Constipation

(1). Adult & children (≧12 years): Dilute 15 mL in 240 mL liqd & drink at least 240 mL. Max: 45 mL/24 hr.

(2). Children

a. 10-11 years: Dilute 15 mL in 240 mL liqd & drink at least 240 mL. Max: 15 mL/24 hr.

b. 5-9 years: Dilute 7.5 mL in 240 mL liqd & drink at least 240 mL. Max: 7.5 mL/24 hr.

2. Bowel cleansing regimen

(1). Prior to surgery or x-ray & endoscopic exam 45 mL in the evening before exam, 45 mL in the morning of exam.

(2). Dilute recommended dose with 1/2 glass of water, drink then followed with 1 full glass of water.

Contraindication:

1. Congenital megacolon, intestinal obstruction or congestive heart failure.

2. Children < 5 years.

Precaution:

1. Renal disease or low salt diet.

2. Pregnancy, lactation. When nausea, vomiting, abdominal pain, sudden change in bowel movement are present.

3. Discontinue if rectal bleeding.

4. Renal impairment, electrolyte imbalance, over-fatigue, co-administration of diuretics or other drugs affecting electrolyte imbalance.

Adverse Reaction: Nausea, vomiting, bloating.
Packaging: 45 ml
CBC Biotechnological & Pharmaceutical Co., Ltd. © 2009 All Rights Reserved. About Us | Partners | Products | R&D | Contact Us 網頁設計Youngday